TipRanks
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
India Market
MARKSANS
Marksans Pharma Limited
RESEARCH TOOLSreports
Want to see IN:MARKSANS full AI Analyst Report?

Marksans Pharma Limited (MARKSANS) Ratios

8 Followers

Marksans Pharma Limited Ratios

IN:MARKSANS's free cash flow for Q1 2027 was ₹0.43. For the 2027 fiscal year, IN:MARKSANS's free cash flow was decreased by ₹ and operating cash flow was ₹0.22. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.00 5.17 4.62 4.78 4.91
Quick Ratio
 0.00 3.32 2.85 3.19 3.49
Cash Ratio
 0.00 1.20 1.04 1.03 1.12
Solvency Ratio
 -0.20 0.64 0.62 0.65 0.75
Operating Cash Flow Ratio
 0.00 0.91 0.43 0.59 0.70
Short-Term Operating Cash Flow Coverage
 0.00 16.27 8.95 7.92 5.71
Net Current Asset Value
₹ 30.53B₹ 19.15B₹ 14.54B₹ 12.67B₹ 12.50B
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.09 0.10 0.09 0.06
Debt-to-Equity Ratio
 0.00 0.11 0.13 0.12 0.07
Debt-to-Capital Ratio
 0.00 0.10 0.12 0.11 0.07
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 0.00 1.28 1.31 1.30 1.26
Debt Service Coverage Ratio
 23.39 8.62 11.72 9.94 6.43
Interest Coverage Ratio
 24.47 20.92 96.81 34.59 32.85
Debt to Market Cap
 0.00 <0.01 <0.01 <0.01 0.01
Interest Debt Per Share
 0.55 8.11 7.36 5.63 3.18
Net Debt to EBITDA
 0.00 -0.48 -0.33 -0.31 -0.65
Profitability Margins
Gross Profit Margin
44.34%39.20%56.39%50.67%50.25%
EBIT Margin
20.65%17.10%16.98%19.97%18.72%
EBITDA Margin
23.82%20.45%20.16%23.38%21.52%
Operating Profit Margin
19.34%17.10%43.04%17.80%16.19%
Pretax Profit Margin
21.77%19.00%19.21%19.45%18.23%
Net Profit Margin
16.29%14.16%14.51%14.41%14.38%
Continuous Operations Profit Margin
16.43%14.23%14.59%14.46%14.33%
Net Income Per EBT
74.83%74.55%75.52%74.07%78.87%
EBT Per EBIT
112.59%111.05%44.65%109.30%112.62%
Return on Assets (ROA)
0.00%10.82%11.75%11.70%12.16%
Return on Equity (ROE)
18.01%13.82%15.43%15.19%15.26%
Return on Capital Employed (ROCE)
0.00%15.14%40.86%16.91%16.21%
Return on Invested Capital (ROIC)
0.00%11.10%30.38%12.29%12.36%
Return on Tangible Assets
0.00%11.30%12.17%12.17%12.80%
Earnings Yield
3.64%5.88%3.78%4.38%9.11%
Efficiency Ratios
Receivables Turnover
 0.00 4.58 4.84 4.74 4.41
Payables Turnover
 0.00 5.33 3.74 4.00 4.00
Inventory Turnover
 0.00 1.85 1.35 1.74 1.90
Fixed Asset Turnover
 0.00 3.14 2.93 3.14 4.79
Asset Turnover
 0.00 0.76 0.81 0.81 0.85
Working Capital Turnover Ratio
 2.89 1.50 1.64 1.55 1.70
Cash Conversion Cycle
 0.00 208.98 247.72 195.76 183.40
Days of Sales Outstanding
 0.00 79.73 75.45 76.93 82.73
Days of Inventory Outstanding
 0.00 197.79 269.83 210.00 192.03
Days of Payables Outstanding
 0.00 68.54 97.56 91.17 91.35
Operating Cycle
 0.00 277.52 345.28 286.93 274.76
Cash Flow Ratios
Operating Cash Flow Per Share
 1.66 10.63 4.56 5.08 5.72
Free Cash Flow Per Share
 0.04 7.75 0.74 0.48 4.42
CapEx Per Share
 1.62 2.88 3.82 4.61 1.29
Free Cash Flow to Operating Cash Flow
 0.03 0.73 0.16 0.09 0.77
Dividend Paid and CapEx Coverage Ratio
 0.69 2.89 1.03 1.00 3.72
Capital Expenditure Coverage Ratio
 1.03 3.69 1.20 1.10 4.43
Operating Cash Flow Coverage Ratio
 0.00 1.40 0.64 0.94 1.93
Operating Cash Flow to Sales Ratio
 0.02 0.16 0.08 0.11 0.13
Free Cash Flow Yield
0.01%4.94%0.34%0.30%6.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 27.42 17.02 26.42 22.83 10.98
Price-to-Sales (P/S) Ratio
 4.47 2.41 3.83 3.29 1.58
Price-to-Book (P/B) Ratio
 4.64 2.35 4.08 3.47 1.68
Price-to-Free Cash Flow (P/FCF) Ratio
 7.10K 20.26 298.02 332.07 15.91
Price-to-Operating Cash Flow Ratio
 188.56 14.77 48.66 31.09 12.32
Price-to-Earnings Growth (PEG) Ratio
 0.58 1.74 1.24 2.87 0.26
Price-to-Fair Value
 4.64 2.35 4.08 3.47 1.68
Enterprise Value Multiple
 18.77 11.30 18.69 13.76 6.69
Enterprise Value
 141.77B 68.20B 98.83B 70.03B 26.65B
EV to EBITDA
 18.77 11.30 18.69 13.76 6.69
EV to Sales
 4.47 2.31 3.77 3.22 1.44
EV to Free Cash Flow
 7.10K 19.43 292.87 324.69 14.50
EV to Operating Cash Flow
 188.56 14.16 47.82 30.40 11.22
Tangible Book Value Per Share
 67.36 63.78 52.44 43.71 39.86
Shareholders’ Equity Per Share
 67.36 66.70 54.45 45.55 42.01
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.24 0.26 0.21
Revenue Per Share
 69.99 65.11 57.89 48.03 44.59
Net Income Per Share
 11.40 9.22 8.40 6.92 6.41
Tax Burden
 0.75 0.75 0.76 0.74 0.79
Interest Burden
 1.05 1.11 1.13 0.97 0.97
Research & Development to Revenue
 0.02 0.00 0.00 0.01 <0.01
SG&A to Revenue
 0.19 0.22 0.11 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.13 1.15 0.54 0.73 0.70
Currency in INR